3/31
06:02 am
otlk
Form EFFECT Outlook Therapeutics,
Medium
Report
Form EFFECT Outlook Therapeutics,
3/28
04:44 pm
otlk
Form 424B3 Outlook Therapeutics,
Medium
Report
Form 424B3 Outlook Therapeutics,
3/20
05:01 pm
otlk
Form S-3 Outlook Therapeutics,
Low
Report
Form S-3 Outlook Therapeutics,
3/14
05:00 pm
otlk
Form 8-K Outlook Therapeutics, For: Mar 11
Low
Report
Form 8-K Outlook Therapeutics, For: Mar 11
3/12
09:11 pm
otlk
Form SCHEDULE 13D/A Outlook Therapeutics, Filed by: GMS Ventures & Investments
Low
Report
Form SCHEDULE 13D/A Outlook Therapeutics, Filed by: GMS Ventures & Investments
3/12
08:56 pm
otlk
Form 4/A Outlook Therapeutics, For: Jan 17 Filed by: Sukhtian Ghiath M.
Low
Report
Form 4/A Outlook Therapeutics, For: Jan 17 Filed by: Sukhtian Ghiath M.
3/10
06:01 am
otlk
Form EFFECT Outlook Therapeutics,
Medium
Report
Form EFFECT Outlook Therapeutics,
3/7
04:21 pm
otlk
Form 424B3 Outlook Therapeutics,
Medium
Report
Form 424B3 Outlook Therapeutics,
3/3
03:59 pm
otlk
Form SCHEDULE 13G Outlook Therapeutics, Filed by: SPHERA FUNDS MANAGEMENT LTD.
Neutral
Report
Form SCHEDULE 13G Outlook Therapeutics, Filed by: SPHERA FUNDS MANAGEMENT LTD.
2/28
04:37 pm
otlk
Form S-3 Outlook Therapeutics,
Medium
Report
Form S-3 Outlook Therapeutics,
2/28
08:18 am
otlk
Form 8-K Outlook Therapeutics, For: Feb 28
Medium
Report
Form 8-K Outlook Therapeutics, For: Feb 28
2/14
05:01 pm
otlk
Form 10-Q Outlook Therapeutics, For: Dec 31
High
Report
Form 10-Q Outlook Therapeutics, For: Dec 31
2/14
04:40 pm
otlk
Form SCHEDULE 13G/A Outlook Therapeutics, Filed by: GREAT POINT PARTNERS LLC
High
Report
Form SCHEDULE 13G/A Outlook Therapeutics, Filed by: GREAT POINT PARTNERS LLC
2/14
04:00 pm
otlk
Form SCHEDULE 13G/A Outlook Therapeutics, Filed by: TANG CAPITAL PARTNERS LP
Medium
Report
Form SCHEDULE 13G/A Outlook Therapeutics, Filed by: TANG CAPITAL PARTNERS LP
2/14
08:14 am
otlk
Form 8-K Outlook Therapeutics, For: Feb 14
Low
Report
Form 8-K Outlook Therapeutics, For: Feb 14
2/10
04:19 pm
otlk
Form ARS Outlook Therapeutics, For: Sep 30
Low
Report
Form ARS Outlook Therapeutics, For: Sep 30
2/10
04:17 pm
otlk
Form DEF 14A Outlook Therapeutics, For: Mar 11
Low
Report
Form DEF 14A Outlook Therapeutics, For: Mar 11
2/6
04:40 pm
otlk
Form 4 Outlook Therapeutics, For: Feb 04 Filed by: Sukhtian Faisal Ghiath
Low
Report
Form 4 Outlook Therapeutics, For: Feb 04 Filed by: Sukhtian Faisal Ghiath
1/31
04:47 pm
otlk
Form PRE 14A Outlook Therapeutics, For: Jan 31
Medium
Report
Form PRE 14A Outlook Therapeutics, For: Jan 31
1/31
04:39 pm
otlk
Form 8-K Outlook Therapeutics, For: Jan 30
High
Report
Form 8-K Outlook Therapeutics, For: Jan 30
1/27
05:05 pm
otlk
Form D Outlook Therapeutics,
Medium
Report
Form D Outlook Therapeutics,
1/23
05:00 pm
otlk
Form 10-K/A Outlook Therapeutics, For: Sep 30
Neutral
Report
Form 10-K/A Outlook Therapeutics, For: Sep 30
1/22
04:18 pm
otlk
Form SCHEDULE 13D/A Outlook Therapeutics, Filed by: GMS Ventures & Investments
Low
Report
Form SCHEDULE 13D/A Outlook Therapeutics, Filed by: GMS Ventures & Investments
1/22
04:11 pm
otlk
Form 4 Outlook Therapeutics, For: Jan 17 Filed by: Sukhtian Ghiath M.
Low
Report
Form 4 Outlook Therapeutics, For: Jan 17 Filed by: Sukhtian Ghiath M.
1/16
05:16 pm
otlk
Form 8-K Outlook Therapeutics, For: Jan 16
Medium
Report
Form 8-K Outlook Therapeutics, For: Jan 16